Antibiotic Release Sheath for Spinal Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing infections during spinal surgery are only partially effective, as bacteria adhering to spinal hardware are recalcitrant to antibiotic therapy, leading to high infection rates and complications, with existing prophylaxis measures failing to maintain supra-therapeutic antibiotic levels post-surgery.
Innovation Solution
An ultrasound-triggered antibiotic release system is introduced, where antibiotics are encapsulated in a reservoir attached to the spinal implant, releasing supra-therapeutic levels when ultrasound is applied, ensuring continuous prophylaxis and eradicating adherent bacteria before they develop into infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are administered systemically or placed during closure, then some prophylactic effect is achieved, but supra-therapeutic antibiotic levels cannot be maintained post-surgery and infection rates remain high
Solution Approach 1:
The patent applies preliminary action by pre-implanting antibiotic-loaded beads into the surgical site during the procedure, ensuring that supra-therapeutic antibiotic levels are immediately available when bacteria are most vulnerable (within hours of surgery) and before systemic antibiotics are depleted. This preemptive placement of antibiotic reservoirs guarantees sustained high concentrations at the critical early post-operative period when infection risk is highest.
Solution Approach 2:
The patent uses antibiotic-loaded beads as an intermediary substance that mediates between the need for high local antibiotic concentrations and the limitations of systemic administration. These beads act as a localized reservoir, releasing antibiotics directly at the surgical site without requiring continuous systemic infusion, thereby maintaining supra-therapeutic levels at the infection risk zone while avoiding systemic side effects.
2Object-affected harmful factors
If debridement is performed to remove adherent bacteria, then bacterial load is reduced, but additional surgery is required and hardware removal may be necessary
Solution Approach 1:
The patent applies preliminary anti-action by delivering high concentrations of antibiotics to the surgical site immediately during or right after the primary surgery, preventing bacteria from establishing firm adherence and biofilm formation in the first place. This proactive approach eliminates the need for subsequent debridement surgeries to remove adherent bacteria, as the antibiotics intercept and eliminate bacterial colonies before they become recalcitrant.
Solution Approach 2:
The patent performs preliminary action by establishing supra-therapeutic antibiotic levels at the surgical site before bacteria can firmly adhere and form biofilms. This timing-critical intervention occurs within the narrow window when bacteria are most susceptible, preventing the development of adherent bacterial populations that would require complex debridement procedures later.
3Ease of operation
If local antibiotic injection is used to treat infection, then targeted delivery is achieved, but additional invasive procedures are required and risk of introducing additional bacteria exists
Solution Approach 1:
The patent applies preliminary action by implanting the antibiotic-loaded beads during the primary surgery itself, rather than requiring separate injection procedures later. This timing ensures that antibiotics are delivered to the surgical site at the critical moment when bacteria are most vulnerable, while also eliminating the need for additional invasive procedures that would carry risks of introducing new bacteria or causing further tissue damage.
4Object-affected harmful factors
If vancomycin is packed around the implant prior to closure, then Gram-positive pathogens are targeted, but comprehensive infection prevention is insufficient due to limited spectrum and variable efficacy
Solution Approach 1:
The patent applies parameter changes by using antibiotic-loaded beads that can be formulated with different antibiotics, combinations of antibiotics, or adjusted concentrations based on the specific surgical risk profile and anticipated pathogens. This flexibility allows customization of the antibiotic regimen to match the particular infection risks of each surgical case, providing broader and more adaptable coverage compared to fixed vancomycin packing protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system significantly reduces spinal infection rates by maintaining high antibiotic concentrations at the surgical site, limiting bacterial resistance, and avoiding the need for invasive drug delivery methods, thereby reducing patient morbidity and mortality.
Implementation Method 1
Noninvasive Ultrasound (US)-triggered acoustic streaming ensures that the antibiotic load is rapidly disseminated around the implant hardware
Implementation Method 2
Noninvasive Ultrasound (US)-triggered acoustic streaming ensures that the antibiotic load is rapidly disseminated around the implant hardware
Implementation Method 3
a porous sheath that surrounds the spinal rod which is further covered with polylactic acid (PLA)
Data Source
AI summary
An implantable medical device having a sheath formed of a polymer material, wherein the sheath forms a reservoir attached to or around the implantable medical device, and wherein the reservoir is sealed with a biocompatible pressure responsive coating; wherein the biocompatible coating is stable for at least 7-day post implantation into a body, and can be mechanically ruptured by application of an exterior pressure generating force.